Market Overview and Company Snapshot
Hubei Jumpcan Pharmaceutical Co., Ltd. (ticker 600566.SS) closed unchanged at a 0 % return during the 24‑hour trading window that ended at 01:31 AM Central Europe on Wednesday, 21 March 2026. The share price sits at approximately CNY 26.70 on the Shanghai Stock Exchange and other major exchanges, reflecting a market capitalization of roughly CNY 24 billion. In the last 24 hours, the firm’s shares have moved a total volume of CNY 308.7 million, with 892.7 million shares available for trading.
Since the end of last month, Hubei Jumpcan has posted a 7.49 % gain, signalling a modest but steady uptick in investor interest. The stock’s 200‑day simple moving average (SMA) currently resides at CNY 25.86, indicating that the price is trading slightly above its long‑term trend. Over the past 52 weeks, the company’s shares have oscillated between a low of CNY 21.13 (recorded on 1 July 2026) and a high of CNY 29.60 (recorded on 11 May 2026). This volatility range offers context for analysts and retail investors alike when assessing the firm’s recent performance.
Comparative Performance of Peer Stocks
In the same trading interval, several peers in the Chinese market exhibited similar flat movement:
| Ticker | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|
| 600583.SS – Offshore Oil Engineering | CNY 6.40 | CNY 28.4 bn | 13.64 |
| 603067.SS – Hubei Zhenhua Chemical | CNY 34.20 | CNY 28.7 bn | 37.78 |
| 000800.SZ – Faw Jiefang | CNY 5.79 | CNY 28.6 bn | 28.43 |
| 600733.SS – Baic Bluepark New Energy | CNY 4.35 | CNY 28.6 bn | — |
| 688538.SS – Everdisplay Optronics Shan | CNY 2.07 | CNY 28.6 bn | — |
All listed peers remained unchanged in the 24‑hour window, underscoring a broader market equilibrium in the Chinese equity landscape. While Hubei Jumpcan’s price action mirrors that of its contemporaries, its underlying fundamentals—particularly its diversified pharmaceutical portfolio—may provide a more stable foundation for future growth.
Company Profile
Hubei Jumpcan Pharmaceutical Co., Ltd. operates within China’s robust healthcare sector, delivering a broad spectrum of pharmaceutical products. Its catalog spans detoxification agents, digestive aids, nervous system drugs, antimicrobials, analgesic anesthetics, hemostatic agents, gynecological medications, and supplementary metal‑material and chemical products. The company’s website, www.jumpcan.com , offers additional insights into its product lines and corporate governance.
Listed on the Shanghai Stock Exchange since its initial public offering on 1 August 2001, Hubei Jumpcan has steadily expanded its market footprint, positioning itself as a noteworthy player in both domestic and international pharmaceutical markets.